MARK A. SMITH, M.D., PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Vistagen Therapeutics, Inc.

Filing Date Source Excerpt
2021-01-14 "Mark A. Smith, M.D., Ph.D. (4)"

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-04-25